MedPath

The penetration of aromatase inhibitor into the cerebrospinal fluid and the response in brain/spinal metastases and meningitis of estrogen receptor positive breast cancer

Not Applicable
Recruiting
Conditions
brain/spinal metastases and meningitis of estrogen receptor positive postmenoposal breast cancer
Registration Number
JPRN-UMIN000013789
Lead Sponsor
Yokohama City University, Department of Surgery
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

under 20 years old, Performance Status>2

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Penetration of aromatase inhibitor into the cerebrospinal fluid
Secondary Outcome Measures
NameTimeMethod
Response to treatment
© Copyright 2025. All Rights Reserved by MedPath